Phase 1/2 study of Chlamydia trachomatis mRNA Vaccine in adults aged 18 to 29 years

Trial Identifier: VAV00023
Sponsor: Sanofi
Start Date: March 2025
Primary Completion Date: January 2028
Study Completion Date: January 2028
Condition: Chlamydia Immunisation

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
AUSTRALIA, Australian Capital Territory Bruce, Australian Capital Territory, AUSTRALIA, 2617
AUSTRALIA, New South Wales Maroubra, New South Wales, AUSTRALIA, 2035
AUSTRALIA, New South Wales Sydney, New South Wales, AUSTRALIA, 2010
AUSTRALIA, Queensland Albion, Queensland, AUSTRALIA, 4010
AUSTRALIA, Queensland Morayfield, Queensland, AUSTRALIA, 4506
AUSTRALIA, Queensland Southport, Queensland, AUSTRALIA, 4222
AUSTRALIA, Victoria Melbourne, Victoria, AUSTRALIA, 3000